Patents by Inventor Chatarina Lofqvist

Chatarina Lofqvist has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for treatment of complications of prematurity comprising administration of IGF-I and IGFBP-3
    Patent number: 9463222
    Abstract: The present invention relates to a composition comprising Insulin Growth Factor I (IGF-I) or an analog thereof in combination with Insulin Growth Factor Binding Protein (IGFBP) or an analog thereof, said combination having a molar ratio of IGF-I to IGFBP 5 being lower than equimolar, preferably in the range from 1:20 to 1:3.33, for use in the treatment of a patient suffering from complications of preterm birth, very preterm birth and/or extremely preterm birth, as well as a method for treating a patient suffering from complications of preterm birth, very preterm birth and/or extremely preterm birth.
    Type: Grant
    Filed: February 9, 2015
    Date of Patent: October 11, 2016
    Assignee: PREMACURE AB
    Inventors: Ann Hellstrom, Chatarina Lofqvist, Lois Smith
  • METHOD AND PRODUCT FOR TREATMENT AND/OR PREVENTION OF COMPLICATIONS OF PREMATURITY
    Publication number: 20150216943
    Abstract: The present invention relates to a composition comprising Insulin Growth Factor I (IGF-I) or an analog thereof in combination with Insulin Growth Factor Binding Protein (IGFBP) or an analog thereof, said combination having a molar ratio of IGF-I to IGFBP being lower than equimolar, preferably in the range from 1:20 to 1:3.33, for use in the treatment of a patient suffering from complications of preterm birth, very preterm birth and/or extremely preterm birth, as well as a method for treating a patient suffering from complications of preterm birth, very preterm birth and/or extremely preterm birth.
    Type: Application
    Filed: February 9, 2015
    Publication date: August 6, 2015
    Applicant: PREMACURE AB
    Inventors: Ann Hellstrom, Chatarina Lofqvist, Lois Smith
  • METHOD AND PRODUCT FOR TREATMENT AND/OR PREVENTION OF COMPLICATIONS OF PREMATURITY
    Publication number: 20130310316
    Abstract: The present invention relates to a composition comprising Insulin Growth Factor I (IGF-I) or an analog thereof in combination with Insulin Growth Factor Binding Protein (IGFBP) or an analog thereof, said combination having a molar ratio of IGF-I to IGFBP being lower than equimolar, preferably in the range from 1:20 to 1:3.33, for use in the treatment of a patient suffering from complications of preterm birth, very preterm birth and/or extremely preterm birth, as well as a method for treating a patient suffering from complications of preterm birth, very preterm birth and/or extremely preterm birth.
    Type: Application
    Filed: July 24, 2013
    Publication date: November 21, 2013
    Applicant: Premacure AB
    Inventors: Ann Hellstrom, Chatarina Lofqvist, Lois Smith
  • Method and product for treatment and/or prevention of complications of prematurity
    Patent number: 8518877
    Abstract: The present invention relates to a composition comprising Insulin Growth Factor I (IGF-I) or an analog thereof in combination with Insulin Growth Factor Binding Protein (IGFBP) or an analog thereof, such combination having a molar ratio of IGF-I to IGFBP being lower than equimolar, preferably in the range from 1:20 to 1:3.33, for use in the treatment of a patient suffering from complications of preterm birth, very preterm birth and/or extremely preterm birth, as well as a method for treating a patient suffering from complications of preterm birth, very preterm birth and/or extremely preterm birth.
    Type: Grant
    Filed: April 18, 2008
    Date of Patent: August 27, 2013
    Assignee: Premacure AB
    Inventors: Ann Hellstrom, Chatarina Lofqvist, Lois Smith
  • METHOD AND PRODUCT FOR TREATMENT AND/OR PREVENTION OF COMPLICATIONS OF PREMATURITY
    Publication number: 20100204101
    Abstract: The present invention relates to a composition comprising Insulin Growth Factor I (IGF-I) or an analog thereof in combination with Insulin Growth Factor Binding Protein (IGFBP) or an analog thereof, said combination having a molar ratio of IGF-I to IGFBP being lower than equimolar, preferably in the range from 1:20 to 1:3.33, for use in the treatment of a patient suffering from complications of preterm birth, very preterm birth and/or extremely preterm birth, as well as a method for treating a patient suffering from complications of preterm birth, very preterm birth and/or extremely preterm birth.
    Type: Application
    Filed: April 18, 2008
    Publication date: August 12, 2010
    Applicant: Premacure AB
    Inventors: Ann Hellstrom, Chatarina Lofqvist, Lois Smith